3 ms·
Which, again, any big pharmaceutical company would have offered to a drug developer, and was in no way a special attribute of Pfizer.
by suction 5y ago
Which, again, any big pharmaceutical company would have offered to a drug developer, and was in no way a special attribute of Pfizer.
- spywaregorilla 5y agoI mean yeah, but it's still a large complicated task. I don't think executing major projects like this should be handwaved because there's alternative options. This is equivalent to saying there's nothing special about biontech as any specialist in novel MRNA vaccines could have developed these. Which did happen, at moderna.